Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)

NCT02774005 is registered in ClinicalTrials.gov with Santhera Pharmaceuticals as lead sponsor.

NCT NCT02774005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02774005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Lead sponsor
Santhera Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2016
Completion date
March 29, 2021
Enrollment
199 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

leber's hereditary optic neuropathy (lhon)